Cargando...
IMMU-30. HIGH-DIMENSIONAL PHENOTYPING OF IMMUNE SUBSETS AND CHECKPOINTS IN THE MOUSE GLIOBLASTOMA MICROENVIRONMENT
Recent clinical trials in glioblastoma have yet to show any benefit of immune checkpoint inhibitors and are mostly driven by the fact that these inhibitors have efficacy in other cancer types. For immunotherapy to succeed in glioblastoma patients, we need to understand the immunological subsets and...
Guardado en:
| Publicado en: | Neuro Oncol |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Oxford University Press
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6216265/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.533 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|